Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer

Figure 6

The association of cisplatin response scores with immunotherapy. (a) The expression values of CD274 and PDCD1 in high-score (HScore) and low-score (LScore) groups. FPKM: fragments per kilobase per million. (b) The correlation matrix showed the correlations between cisplatin response scores (CisRS) and CD274 and PDCD1. (c) The cisplatin response scores and expression values of PRF1 and GZMA between the four groups, isotype control, anti-PD-L1 treated, anti-PD-1 treated, and bispecific anti-PD-1/PD-L1 treated. TPM: transcripts per million.

(a)

(b)

(c)